These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19002597)

  • 1. The analysis of metastasis in transgenic mouse models.
    Hüsemann Y; Klein CA
    Transgenic Res; 2009 Feb; 18(1):1-5. PubMed ID: 19002597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models of breast cancer metastasis.
    Fantozzi A; Christofori G
    Breast Cancer Res; 2006; 8(4):212. PubMed ID: 16887003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of thrombospondin-1 on breast cancer metastasis.
    Yee KO; Connolly CM; Duquette M; Kazerounian S; Washington R; Lawler J
    Breast Cancer Res Treat; 2009 Mar; 114(1):85-96. PubMed ID: 18409060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic pathways modulated by Twist in breast cancer.
    Vesuna F; Bergman Y; Raman V
    BMC Cancer; 2017 Jan; 17(1):52. PubMed ID: 28086829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of bone metastasis.
    Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH
    Cancer; 2003 Feb; 97(3 Suppl):748-57. PubMed ID: 12548572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods to Study Metastasis in Genetically Modified Mice.
    Kabeer F; Beverly LJ; Darrasse-Jèze G; Podsypanina K
    Cold Spring Harb Protoc; 2016 Feb; 2016(2):pdb.top069948. PubMed ID: 26832689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.
    Kerbel RS; Guerin E; Francia G; Xu P; Lee CR; Ebos JM; Man S
    Breast; 2013 Aug; 22 Suppl 2():S57-65. PubMed ID: 24074794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
    Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM
    Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.
    Song H; Shahverdi K; Huso DL; Wang Y; Fox JJ; Hobbs RF; Gimi B; Gabrielson KL; Pomper MG; Tsui BM; Bhujwalla Z; Reilly RT; Sgouros G
    Clin Cancer Res; 2008 Oct; 14(19):6116-24. PubMed ID: 18829490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling human breast cancer metastasis in mice: maspin as a paradigm.
    Shi HY; Zhang W; Liang R; Kittrell F; Templeton NS; Medina D; Zhang M
    Histol Histopathol; 2003 Jan; 18(1):201-6. PubMed ID: 12507299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
    Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
    Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
    Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
    Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    Paez-Ribes M; Man S; Xu P; Kerbel RS
    PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo xenograft models of breast cancer metastasis.
    Valentiner U; Brooks SA; Schumacher U
    Methods Mol Med; 2006; 120():479-88. PubMed ID: 16491620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease progression model of 4T1 metastatic breast cancer.
    Yang L; Yong L; Zhu X; Feng Y; Fu Y; Kong D; Lu W; Zhou TY
    J Pharmacokinet Pharmacodyn; 2020 Feb; 47(1):105-116. PubMed ID: 31970615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis from human breast cancer cell lines.
    Price JE
    Breast Cancer Res Treat; 1996; 39(1):93-102. PubMed ID: 8738609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
    Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
    Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells.
    Punzi S; Balestrieri C; D'Alesio C; Bossi D; Dellino GI; Gatti E; Pruneri G; Criscitiello C; Lovati G; Meliksetyan M; Carugo A; Curigliano G; Natoli G; Pelicci PG; Lanfrancone L
    Breast Cancer Res; 2019 Nov; 21(1):123. PubMed ID: 31752957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.